Skip to main content
Clinical Trials/NCT06626360
NCT06626360
Recruiting
Not Applicable

SCreening fOr Malnutrition and Obesity in Patients With COVID-19 and Other Diseases

HAN University of Applied Sciences3 sites in 1 country2,000 target enrollmentOctober 2, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Overweight and Obese Adults
Sponsor
HAN University of Applied Sciences
Enrollment
2000
Locations
3
Primary Endpoint
Malnutrition
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

More than half of the Dutch population is overweight or obese, which is associated with an increased risk of COVID-19 and worse outcomes during a COVID-19 infection. In addition, malnutrition and loss of muscle mass are often reported with COVID-19, as well as with cancer and other diseases. Malnutrition and overweight or obesity can coexist, even within the same individual. It is still unclear which mechanisms contribute to the worse outcomes of COVID-19 and other diseases in case of overweight, malnutrition, and a combination of both. The aim of this study is to identify which parameters are associated with worse disease outcomes through literature research and database research (COVID-19 and cancer, more than 150.000 participants). In addition, a clinical study will be conducted aiming to develop a simple screening tool for the recognition of the coexistence of malnutrition and overweight or obesity in clinical practice.

Detailed Description

Overweight and malnutrition are both common and have a significant societal impact as well as a negative effect on healthcare. They can also coexist, and may potentially reinforce each other. How the combination of both influences the course of COVID-19 and other diseases is still largely unknown. There is no simple set of parameters yet available to screen for the simultaneous occurrence of overweight and malnutrition. This project has the following objectives: * To evaluate the nutritional status (malnutrition, overweight, and the combination of both) and the (dietary) treatment of patients with COVID-19 in primary care (WP1). * To assess the influence of various parameters of malnutrition and overweight and their effects on the outcomes of COVID-19 and cancer based on literature and data from existing Dutch cohorts (WP2 and WP3). Based on this, to develop a screening tool for malnutrition in overweight; (WP4). - Dissemination of the results (WP5).

Registry
clinicaltrials.gov
Start Date
October 2, 2024
End Date
August 31, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

dr. Marian de van der Schueren

Professor of Nutrition, Dietetics and Lifestyle

HAN University of Applied Sciences

Eligibility Criteria

Inclusion Criteria

  • Age 18 years or older
  • Overweight (BMI of 25 kg/m² or higher)

Exclusion Criteria

  • Physically or mentally unable to participate.
  • Severe cognitive disorder or severe emotional instability, as assessed by the attending nurse or physician.
  • Insufficient proficiency in the Dutch language to express themselves properly and no interpreter or assistant to help.
  • Patient resides in a nursing or care home.

Outcomes

Primary Outcomes

Malnutrition

Time Frame: 9 months

Malnutrition will be assessed by a working definition based on the GLIM-criteria and a Delphi-study

Study Sites (3)

Loading locations...

Similar Trials